Header Logo

Connection

FILIP JANKU to Long QT Syndrome

Back to Details
This is a "connection" page, showing publications FILIP JANKU has written about Long QT Syndrome.
FILIP JANKU
Connection Strength
0.147
Long QT Syndrome
  1. Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies. Cancer Chemother Pharmacol. 2018 06; 81(6):1129-1141.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.